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Summary The haemodynamics of the uterine arteries and myometrium were assessed using Doppler
ultrasound in forty consecutive patients requiring treatment for invasive mole and choriocarcinoma. The
investigations were performed prior to the commencement of chemotherapy and the subjects followed
prospectively. The Doppler waveforms from the uterine arteries were analysed using the pulsatility index. It
was found that patients with a pulsatility index of 1.1 or less were significantly more likely to develop drug
resistance than those with a higher value (P<0.04). There was no significant association between the
pulsatility index and metastatic disease or uterine bleeding. Five out of eight patients who developed drug
resistance could have avoided initial inadequate treatment if the Doppler findings were included in the scoring
system for selecting chemotherapy for these tumours. It can be concluded that assessment of the uterine
arteries using the pulsatility index prior to the treatment of patients with invasive mole and choriocarcinoma is
of help in predicting those who will develop drug resistance.
Invasive mole and choriocarcinoma have a combined
incidence of approximately 100 cases in the United Kingdom
each year. They occur in approximately 8% of women who
have had a molar pregnancy but can occur as a rare comp-
lication of full term delivery, spontaneous miscarriage or
termination of pregnancy (Bagshawe et al., 1986). Although
these tumours are rare they are important because they occur
in young women and are rapidly fatal without treatment. The
use of cytotoxic chemotherapy and the introduction of the
hydatidiform mole registration system, thereby allowing early
detection of trophoblastic tumours, have effected a 97% cure
rate for these tumours (Newlands et al., 1986). The main
centre for the treatment of trophoblastic tumours in the
United Kingdom is at the Charing Cross Hospital, London,
where three chemotherapeutic regimens are used ranging
from low to high toxicity. The cytotoxic drug protocol
selected for a patient is based on a clinical and biochemical
scoring system which assesses the patient's risk of developing
resistance to therapy which is either low, medium or high
(Bagshawe, 1976). Thus, curative chemotherapy can be insti-
tuted without exposing every patient to the toxicity associ-
ated with multiple agent cytotoxic drugs. However, despite
this scoring system a proportion of patients still develop drug
resistance or relapse after apparently successful initial chemo-
therapy (Newlands et al., 1986). In this study three out of 76
(4%) of medium risk cases relapsed but were successfully
retreated whilst in previously untreated high risk patients one
out of 29 (3%) relapsed and with a maximum of 9 years
follow-up the survival is 79%. Thus, it is still necessary to
investigate methods which may aid the prediction of tumour
behaviour and optimise first line chemotherapy.
Ultrasound has been shown to aid the diagnosis of
hydatidiform mole (MacVicar & Donald, 1963; Leopold,
1971) and Woo et al. (1985) suggested that it may be of use
in monitoring the response to treatment of patients with
persistent trophoblastic tumours. However, a subsequent
study has shown that real-time ultrasound is not of use in
predicting those patients who will relapse after first line
chemotherapy (Long et al., 1990a). Studies using arterio-
graphic techniques have demonstrated an abnormal uterine
circulation in patients with invasive mole and choriocar-
cinoma (Borrell & Fernstom, 1958; Brewis & Bagshawe,
1968) but this did not aid clinical management. The develop-
ment of Doppler ultrasound enables a non-invasive assess-
ment of haemodynamics (Gosling, 1976; Skidmore & Wood-
cock, 1980) and is potentially superior to angiography as it
reveals information about the physiological state of the cir-
culation of an organ. It has been shown that the Doppler
ultrasound characteristics of the uterine circulation in
patients with invasive mole and choriocarcinoma differ from
both the normal non-pregnant and early pregnant states
(Long et al., 1990b). This paper examines the relationship
between the haemodynamics of the uterine vasculature, as




Forty consecutive patients referred for first line cytotoxic
chemotherapy for trophoblastic tumours were investigated
prior to the commencement of treatment. Details of the risk
group in which the patient had been placed, the presence of
metastases and uterine bleeding according to the WHO
classification were obtained from the case records. The
patients were prospectively followed and their response to
chemotherapy was monitored using serial human chorionic
gonadotrophin (hCG) assays (Kardana & Bagshawe, 1976).
Drug resistance was defined as a failure of the hCG concen-
trations to fall satisfactorily in response to appropriate
chemotherapy.
Scanning technique
The subjects were required to have a full bladder to allow
good ultrasonic access to the pelvic structures by displacing
bowel around the uterus and ovaries. Urine in the bladder
produces virtually negligible attenuation to ultrasound and
therefore acts as an acoustic window.
The uterine volume was calculated using the prolate ellip-
soid formula where:
Volume (cm3) = L (cm) x A-P (cm) x W (cm) x 0.523
(L = length, A-P = maximum antero-posterior diameter and
W = maximum width).
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The Doppler investigations were carried out using a
Diasonics DRF 400 duplex scanner with a 3.5 MHz transab-
dominal mechanical sector probe. The returned Doppler
shifted frequencies were processed via an on-line spectrum
analyser with a high pass filter set at 150 Hz.
The frequency spectra from the uterine arteries can be
detected by scanning transversely at a level just above and
adjacent to the supravaginal portion of the cervix (Long et
al., 1989). This is the point where the uterine artery ascends
the lateral borders of the uterus after its course in the base of
the broad ligament (Figure 1). Care was taken not to scan
above this level as signals from the anastomosis of the
uterine artery with the ovarian artery may be included in the
returned signals. Three consecutive waveforms were recorded
and the procedure was repeated on the opposite side. The
myometrium was sampled at several points in both the lon-
gitudinal and transverse planes.
Signal analysis
Blood velocity can be calculated from the frequency spectra
generated using the Doppler equation providing the angle of
the insonating ultrasound beam to the vessel under investiga-
tion is known. The Doppler equation is:
df c
v 2f cos 0
where v is the velocity of the blood, df is the Doppler change
in frequency of the ultrasound beam after reflection from the
moving column of blood, c is the speed of ultrasound in
tissue (1540 m/s), f is the insonating ultrasonic frequency
(3.5 MHz) and 0 is the angle at which the ultrasound beam
subtends to the vessel of interest. In the case of the uterine
arteries it is inaccurate to measure the angle 0 because of
their small diameter and tortuous course. Therefore, the
pulsatility index (PI) (Gosling, 1976), which is independent of
the angle of insonation, was chosen to analyse the
waveforms. This is defined as:
PI = A-B mean
Where taking into consideration the waveform envelope over
a cardiac cycle, A is the maximum change in frequency
during systole, B is the minimum frequency change in dia-
stole and mean is the average frequency change (Figure 2).




Figure 2 Calculation of the Pulsatility Index.
Figure 1 Transverse ultrasound scan at a level just above the supravaginal portion of the cervix demonstrating the uterine artery
(arrowed).
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the point of sampling. Providing the proximal conditions of
flow remain constant, an increase in distal impedence will
result in an increase in the PI and vice versa.
Reproducibility
The uterine artery waveform was detected and recorded in 10
normal non-pregnant subjects and the pulsatility indexes cal-
culated. The ultrasound probe was then removed from the
abdomen and the waveform was relocated after a time inter-
val of at least 5 min and assessed. The coefficient of variation
was found to be 8.8% (Long et al., 1989).
Results
Pulsatility Index ofthe uterine arteries
The lowest PI obtained from the two uterine arteries was
used in the analysis as this would reflect the maximal devia-
tion from the normal impedance flow. The mean pulsatility
index was 1.43 (s.d. 0.81) with a range of 0.44 to 3.06. These
values reflect a distribution of waveform shapes which pro-
gress from a normal (Figure 3a) through to a low impedance
to flow (Figure 3b).
Drug resistance
Eight out of the 40 women studied developed drug resistance
to chemotherapy. The mean PI in the group of patients who
did and did not develop drug resistance was 0.99 (s.d. 0.62)
and 1.56 (s.d. 0.83) respectively (Figure 4). There was a
significant statistical difference between the PI's of the two
groups (Mann-Whitney U test, P<0.03). Sequential analysis
of the PI's showed that patients who have a value of 1.1 or
less were significantly more likely to develop drug resistance







No resistance Drug resistance
Figure 4 The pulsatility indexes of patients who did not develop
(mean 1.56, s.d. 0.83) and who did develop (mean 0.99, s.d. 0.62)
drug resistance to chemotherapy.
a
b
Figure 3 Uterine artery doppler shift waveforms from a, a normal non-pregnant subject and b, a patient with gestational
trophoblastic disease.
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The results were applied to the existing scoring system in
order to assess whether the PI of the uterine arteries would
aid patient management. Those patients who had a PI of less
than 1.1 were ascribed an additional score of 2 to the present
scoring system. No additional score was added to those cases
with a PI of greater than 1.1. five out of the eight patients
with drug resistance would have benefitted by increasing their
score so that they were included in a higher risk group. In
two cases this meant changing from low to middle risk and
in three cases changing from middle to high risk. Two sub-
jects who developed drug resistance and who had a PI of less
than 1.1 were already assigned to the high risk group on the
original scoring system. Only one of the 32 women who did
not develop drug resistance would have been ascribed to
higher risk group based on the Doppler findings. Conversely,
one subject who had a PI of greater than 1.1 went on to
develop drug resistance. Eight other patients with a pul-
satility index of less than 1.1 did not develop drug resistance,
but increasing their score did not assign them to a higher risk
category.
Metastatic disease and uterine bleeding
Nine cases had metastatic disease and 19 had uterine bleed-
ing by WHO criteria. There was no significant association
between the PI of those patients who had metastatic disease
(mean 1.46; s.d. 0.86) or uterine bleeding (mean 1.49;
s.d. 0.79) and those who did not have these complications
(mean 1.33; s.d. 0.59 and mean 1.36; s.d. 0.84 respec-
tively).
Uterine volume and hCG
The mean uterine volume was 245 cm3 (s.d. 160) with a range
of 40 to 700cm3. There was a trend for the PI to decrease as
uterine volume increased but this association was not
significant using regression analysis (P> 0.05).
The mean hCG value was 62,430 iu 1' (s.d. 158,830) with
a range of 3 to 717,980 iu1-'. Again, there was no significant
relationship between initial hCG values and the PI
(P= 0.8).
Myometrial signals
Thirty-five out of the 40 patients (83%) investigated had
Doppler signals returned from the myometrium. These could
either be localised or diffuse and demonstrated both pulsatile
and uniform velocities. All patients who did not have Dop-
pler shifted signals from the myometrium had a PI of greater
than 1.1. There was no correlation between the presence of
myometrial signals and the development of drug resistance or
the presence of metastatic disease or uterine bleeding.
Discussion
The results show that impedance to blood flow in the uterine
arteries in women who require treatment for gestational
trophoblastic tumours is related to the clinical course of the
disease. A previous study using Doppler ultrasound has
investigated the uterine circulation in normal non-pregnant
women and the 95% lower confidence interval for the pul-
satility index of the uterine artery was 1.21 (Long et al.,
1989). The pulsatility indexes of patients with invasive mole
or choriocarcinoma in the present study ranged from values
expected at the lower end for non-pregnant women to those
throughout the early stages of pregnancy (Long et al.,
1990b). Those women with trophoblastic tumours who
developed drug resistance had a significantly lower pulsatility
index than those who did not. However, using information
based on non-pregnant women did not help establish a cut
off level for the pulsatility index to predict those who would
develop drug resistance. Therefore, sequential analysis was
performed using decreasing values of pulsatility index to
obtain a threshold level.
Although statistical significance was reached between
patients who did and did not develop drug resistance using a
pulsatility index level of 1.1 there were still nine subjects who
had a pulsatility index of less than this and who were not
refractory to chemotherapy. However, by utilising an addi-
tional score of 2 to the present scoring system only one case
in this group would have had multiple agent chemotherapy
(which was from low to middle risk regimens), whereas five
out of the eight women who developed drug resistance would
have started on a higher risk protocol and avoided initial
inadequate treatment. Of the remaining three cases of drug
resistance two were already ascribed to the high risk groups
with one requiring the use of cis-platinum followed by
hysterectomy and the other requiring cis-platinum alone.
Although the current scoring system does not include a
formal ultra-high risk group it is possible that this additional
information could be incorporated into the initial assessment.
If these findings are confirmed in a larger group of patients
initial therapy including cis-platinum and/or marrow support
with haemopoietic growth factors might prevent the develop-
ment of drug resistance in these cases. In only one case was
the pulsatility index of the uterine artery above 1.1 with the
development of drug resistance. This case was initially
allocated to the low risk group and successfully treated after
changing to the middle risk regimen.
There are two possible mechanisms which would account
for the relationship between a low impedance to flow in the
uterine arteries and the development ofdrug resistance. First-
ly, the low impedance reflects the presence of arterio-venous
shunts within the uterus. This may have the effect of decreas-
ing the perfusion of the tumour which has been shown to be
relatively avascular within itself (Elston, 1976). Thus,
penetration of the cytotoxic drugs would be reduced and
their effectiveness diminished leading to the development of
clinical drug resistance.
Alternatively, drug resistance could develop due to intrin-
sic properties of the tumour itself. The capacity of different
trophoblastic tumours to induce vascular changes could also
be related to the presumed biochemical basis of drug resis-
tance. Choriocarcinoma is derived from villus cytotropho-
blast and is very responsive to cytotoxic treatment but the
corresponding tumour derived from interstitial cytotropho-
blast is resistant to- chemotherapy (Scully & Young 1981;
Eckstein et al., 1982). In normal pregnancy it is the inter-
stitial cytotrophoblast which is thought to be responsible for
the spiral artery dilatation and the reduction in the
impedance to flow in the uterine arteries (Pijnenborg et al.,
1983). Thus, the low impedance to blood flow in the group of
patients who developed drug resistance may be a result of
those tumours containing a proportion of cells from an
interstitial cytotrophoblastic origin which would intrinsically
reduce the sensitivity of the tumour to therapy. There was no
association between the pulsatility indices and metastatic
disease or vaginal bleeding. These findings may be explained
by the invasive properties of trophoblastic tissue which can
lead to blood vessel invasion without any gross interference
to the uterine circulation.
The impedance of the uterine circulation tended to
decrease as uterine volume increased although this relation-
ship was not significant. Increased uterine volume is a result
of tumour size and therefore the greater the trophoblastic
tissue requiring treatment. The reduced impedance to blood
flow in these patients may be a consequence of the general-
ised increase in uterine volume.
Myometrial Doppler shift signals are limited in the non-
pregnant uterus (Long et al., 1989) but over 80% of the
study group had myometrial blood flow detected. The
majority of these cases had a pulsatility index of greater than
1.1 and did not relate to the clinical course of the tumour.
The myometrial signals are a non-specific finding which is
likely to be a result of local infiltration of the myometrial
vessels or a degree of neovascularisation around the tumour
nodule.
In conclusion, the results presented indicate a relationship
between the Doppler ultrasound haemodynamics of theDOPPLER ASSESSMENT OF UTERINE CIRCULATION 887
uterine circulation and the development of resistance to
cytotoxic chemotherapy in patients requiring treatment for
invasive mole and choriocarcinoma. The Doppler inform-
ation obtained prior to chemotherapy is being applied to a
larger group of patients. If the findings presented are
confirmed then the pulsatility index will be incorporated into
the current scoring system to select treatment protocols for
the management of these diseases.
We would like to thank the Cancer Research Campaign for their
support with this project.
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